The Pharmaceutical Rivalry Behind the Weight-Loss Drug Boom
Big Take25 Jan 2024

The Pharmaceutical Rivalry Behind the Weight-Loss Drug Boom

The multi-billion dollar weight-loss drug market has ballooned in the past few years. And the two pharmaceutical companies currently duking it out for market dominance, Novo Nordisk and Eli Lilly, have a century-long rivalry.

Bloomberg News health reporter Madison Muller breaks down how Eli Lilly developed Zepbound, a new drug that can help patients cut more than 20% of their body weight — and why some investors and analysts think it will turn Eli Lilly into the first ever trillion-dollar drug company.

(Corrects characterization of the current size of the weight-loss drug market)

See omnystudio.com/listener for privacy information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(964)

How India’s Cockroach Party Became a Political Force

How India’s Cockroach Party Became a Political Force

Weeks of student-led protests forced the resignation of India’s education minister, in a rare public setback for Prime Minister Narendra Modi. On today’s Big Take Asia podcast, guest host Rebecca Choo...

28 Jul 18min

Trump Rebuilds His Tariff Wall, Brick by Brick

Trump Rebuilds His Tariff Wall, Brick by Brick

As President Trump paused strikes on Iran over the weekend, he ratcheted up pressure on another front: his renewed trade war. On Friday, the US president imposed levies of 10 or 12.5% on 60 economies,...

27 Jul 16min

Weekend Listen: Can the US Actually Tax Billionaires?

Weekend Listen: Can the US Actually Tax Billionaires?

As wealth becomes increasingly concentrated — and artificial intelligence threatens to shift even more income from workers to investors — has the US tax system become outdated? On this Weekend Listen,...

26 Jul 23min

One Weird Trick to Get Your Credit Card Charge Reversed? Fraud.

One Weird Trick to Get Your Credit Card Charge Reversed? Fraud.

American consumers disputed nearly 30% more credit card transactions in 2025 than they did just four years earlier. Some of those “chargebacks” are legitimate issues or outright scams. But increasingl...

24 Jul 15min

Almost $1 Billion Later, the US Still Can’t Manufacture Medical Gloves

Almost $1 Billion Later, the US Still Can’t Manufacture Medical Gloves

After the pandemic-era run on medical gloves, the US government set a plan in motion to reshore manufacturing. Roughly six years and almost $1 billion later, America is once again facing potential sho...

23 Jul 16min

The Trump Insiders Who Shaped Crypto Law

The Trump Insiders Who Shaped Crypto Law

How did Tether — the largest stablecoin issuer in the world — go from fighting stablecoin regulation to supporting the Genius Act? That’s the subject of a new Bloomberg News investigation into how Tru...

22 Jul 20min

Chasing the Ancient Stolen Statues of Cambodia

Chasing the Ancient Stolen Statues of Cambodia

When a 1,000-year-old Cambodian statue came up for auction at Sotheby’s in New York, it sparked off an investigation that uncovered one of the world’s most extensive art trafficking networks. On today...

21 Jul 20min

Polymarket and Kalshi Grapple With A New Class of Insider Trader

Polymarket and Kalshi Grapple With A New Class of Insider Trader

From celebrity wedding details to the timing of military strikes, prediction markets have opened the door to gambling on almost anything. They’ve also created a new class of insider trader that platfo...

20 Jul 20min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
forklart
stopp-verden
popradet
rss-gukild-johaug
aftenpodden-usa
fotballpodden-2
dine-penger-pengeradet
rss-ness
hanna-de-heldige
aftenbla-bla
det-store-bildet
e24-podden
rss-penger-polser-og-politikk
lydartikler-fra-aftenposten
unitedno
rss-utenrikskomiteen-med-bogen-og-grasvik
liverpoolno-pausepraten
oppdatert